/PRNewswire/ -- The report has been added to offering.
Glaxo (GSK) signs deal with iTeos Therapeutics to co-develop its investigational cancer candidate known as EOS-448. Glaxo will also study EOS-448 with its other investigational cancer therapies.
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that Deborah H. Telman and Maggie Yuen have been...
As per Market Research Future (MRFR), the Global Membrane Chromatography Market is anticipated to achieve USD 635 Million by 2027 at a 17.5% CAGR. The development in the pharmaceutical industry has contributed...
/PRNewswire/ -- KVK-Tech, Inc. (KVK) and its affiliate Penn Life Sciences, Inc. (PLS) have announced that they have appointed Ram Kamineni as Chief Operating Officer, effective .
Global Immunology Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional...
Bristol Myers (BMY) announces positive data on CAR T cell therapy, Breyanzi, in the second-line setting for patients with relapsed or refractory large B-cell lymphoma.
Benchmarks closed in the green as investors shrugged off inflation report in agreement with the Fed's argument that jump in prices is temporary as demand exceed supply on account of the economy's recovery...
Japan, Japan, Fri, 11 Jun 2021 07:33:17 / Comserve Inc. / -- Electronic Chemicals Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing Technologies,...
Japan, Japan, Fri, 11 Jun 2021 07:38:53 / Comserve Inc. / -- Resorbable (Bioresorbable) Polymers Market With Top Countries Data, Industry Analysis , Size, Share, Revenue, Prominent Players, Developing...
FDA approves Novo Nordisk's (NVO) obesity treatment, Wegovy and Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine, Prevnar 20.
Merck (MRK) is set to supply 1.7 million courses of its oral COVID-19 therapy candidate, molnupiravir, worth $1.2 billion to the U.S. government, following a potential approval or authorization.
Transcarent, a new and different consumer-directed health and care experience for employees of self-insured employers and their families, today announced a $58 million Series B investment led by General...
The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to discover innovative and effective therapies for the treatment...
Canada's main stock index opened lower on Wednesday as financial stocks declined following the central ...
Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine candidate helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with the United States government for molnupiravir (MK-4482). Molnupiravir...
Reportlinker.com announces the release of the report "Antivirals Global Market Report 2021: COVID 19 Implications And Growth to 2030" - https://www.reportlinker.com/p06090622/?utm_source=GNW
Reportlinker.com announces the release of the report "Fertility Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06090623/?utm_source=GNW
Reportlinker.com announces the release of the report "Oligonucleotide Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030" - https://www.reportlinker.com/p06090627/?utm_source=GNW
